STOCKHOLM , July 23, 2024 /PRNewswire/ — BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) today announced that its partner Eisai will present the latest findings on lecanemab (generic name, brand name Leqembi®) at the Alzheimer’s Association International Conference (AAIC) 2024. The…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.